Table 1.
CS/TPP Weight Ratio | Ciprofloxacin Hydrochloride (mg/mL) | Average Particle Size (nm) | Polydispersity (PDI) | Zeta Potential (mV) | Encapsulation Efficiency (%) |
---|---|---|---|---|---|
5:1 (CS 1 mg/mL) & TPP (0.5 mg/mL) Formulation 1 |
0.5 | 195.6 ± 11 | 0.249 | +24.86 ± 1.2 | 43 ± 2.29% |
1 | 185.5 ± 2 | 0.217 | +24.91 ± 0.6 | 42 ± 2.35% | |
5:1 (CS 2 mg/mL) & PP (1 mg/mL) Formulation 2 |
0.5 | 214.8 ± 8 | 0.249 | +29.6 ± 0.8 | 46 ± 2.15% |
1 | 252.9 ± 9 | 0.254 | +27.0 ± 0.7 | 43 ± 2.27% | |
9:1 (CS 1 mg/mL) & TPP (1 mg/mL) Formulation 3 |
0.5 | 229.1 ± 13 | 0.250 | +28.35 ± 2.6 | 43 ± 2.25% |
1 | 235.4 ± 16 | 0.289 | +29.31 ± 2.1 | 43 ± 4.54% |